{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:02Z","timestamp":1793978882303,"version":"4.8.0"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/06397\/2025"],"award-info":[{"award-number":["UID\/06397\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119264","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T15:13:17Z","timestamp":1787411597000},"page":"119264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cysteine-targeting covalent inhibition: Recent trends and emerging strategies"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-3219","authenticated-orcid":false,"given":"Mariana","family":"Castel\u00f4a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-2402","authenticated-orcid":false,"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Benfeito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chavarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119264_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/acschembio.1c00980","article-title":"Improved electrophile design for exquisite covalent molecule selectivity","volume":"17","author":"Monta\u00f1o","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib2","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1021\/acs.jmedchem.2c02074","article-title":"Rhenium(V) complexes as cysteine-targeting coordinate covalent warheads","volume":"66","author":"Karges","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib3","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1021\/jacs.1c13568","article-title":"Covalent proximity scanning of a distal cysteine to target PI3K\u03b1","volume":"144","author":"Borsari","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib4","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1021\/acs.jmedchem.1c01165","article-title":"Development of the first covalent monopolar spindle kinase 1 (MPS1\/TTK) inhibitor","volume":"65","author":"Serafim","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acschembio.3c00805","article-title":"Reversible covalent inhibition\u2500desired covalent adduct formation by mass action","volume":"19","author":"Patel","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib6","first-page":"120","article-title":"Inhibiting androgen receptor splice variants with cysteineselective irreversible covalent inhibitors to treat prostate cancer","author":"Thiyagarajan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119264_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107805","article-title":"Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs): a 2025 update","volume":"217","author":"Roskoski","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119264_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117761","article-title":"New drugs approved by European medicines agency during 2024","volume":"294","author":"Hu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00044-023-03065-3","article-title":"An update on the discovery and development of reversible covalent inhibitors","volume":"32","author":"Faridoon","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119264_bib10","article-title":"Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: a review","volume":"12","author":"Hameed","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.ejmech.2026.119264_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2533\/chimia.2023.349","article-title":"Understanding intrinsic warhead reactivity and cysteine druggability in covalent drug discovery: medicinal chemistry and chemical biology highlights","volume":"77","author":"Borsari","year":"2023","journal-title":"CHIMIA"},{"key":"10.1016\/j.ejmech.2026.119264_bib12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/acs.chemrev.4c00745","article-title":"Targeted covalent modification strategies for drugging the undruggable targets","volume":"125","author":"Tamura","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119264_bib13","article-title":"Probing the protein Kinases' cysteinome by covalent fragments","volume":"64","author":"Wang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123917","article-title":"Radical nucleophilic substitution\/cyclization: a novel strategy for selective and ultrafast fluorescence imaging of cysteine levels in ferroptosis process","volume":"253","author":"Zhao","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2026.119264_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acschembio.2c00727","article-title":"Widespread, reversible cysteine modification by methylglyoxal regulates metabolic enzyme function","volume":"18","author":"Coukos","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chembiol.2025.12.003","article-title":"An interactive resource mapping the proteome and reactive cysteine landscape across the NCI-60 reveals cell and tissue-specific profiles","volume":"33","author":"Monta\u00f1o","year":"2026","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib17","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1021\/acs.jmedchem.2c00067","article-title":"Construction of covalent bisubstrate inhibitor of protein kinase reacting with cysteine residue at substrate-binding site","volume":"65","author":"S\u00f5rmus","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib18","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1021\/acs.jmedchem.2c00336","article-title":"N-Acylamino saccharin as an emerging cysteine-directed covalent warhead and its application in the identification of novel FBPase inhibitors toward glucose reduction","volume":"65","author":"Wen","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib19","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1021\/acs.jcim.3c00004","article-title":"Benchmarking in silico tools for cysteine pKa prediction","volume":"63","author":"Awoonor-Williams","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119264_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1021\/acs.jcim.4c01281","article-title":"CovCysPredictor: predicting selective covalently modifiable cysteines using protein structure and interpretable machine learning","volume":"65","author":"Reimer","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119264_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2022.100040","article-title":"Covalent chemical probes for protein kinases","volume":"3","author":"Serafim","year":"2023","journal-title":"Curr. Res. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib22","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1021\/acs.jmedchem.2c00909","article-title":"Tunable cysteine-targeting Electrophilic heteroaromatic warheads induce ferroptosis","volume":"65","author":"Karaj","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105422","article-title":"Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)","volume":"165","author":"Roskoski","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119264_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119264_bib25","article-title":"The expanding repertoire of covalent warheads for drug discovery","volume":"null","author":"Namrashee","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119264_bib26","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1021\/acs.jmedchem.5c00884","article-title":"A \u201cLigand First\u201d approach toward selective, covalent JNK2\/3 inhibitors","volume":"68","author":"Wydra","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112740","article-title":"Covalent inhibitors of GAPDH: from unspecific warheads to selective compounds","volume":"207","author":"Galbiati","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111366","article-title":"Reactivity of covalent fragments and their role in fragment based drug discovery","volume":"15","author":"McAulay","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119264_bib29","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.3390\/ijms24065960","article-title":"HyperCys: a Structure- and sequence-based predictor of hyper-reactive druggable cysteines","volume":"24","author":"Gao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib30","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.jcim.9b01058","article-title":"BIreactive: a machine-learning model to estimate covalent warhead reactivity","volume":"60","author":"Palazzesi","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119264_bib31","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/acs.jctc.3c00232","article-title":"Integrated covalent drug design workflow using site identification by ligand competitive saturation","volume":"19","author":"Yu","year":"2023","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejmech.2026.119264_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf697","article-title":"The covalent docking software landscape: features and applications in drug design","volume":"26","author":"Singh","year":"2025","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ejmech.2026.119264_bib33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/acs.accounts.5c00905","article-title":"Computational and AI-Driven ecosystem for structure-based covalent drug discovery","volume":"59","author":"Li","year":"2026","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119264_bib34","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1021\/acs.jmedchem.1c00172","article-title":"Covalent small molecule immunomodulators targeting the protease active site","volume":"64","author":"Kim","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115212","article-title":"Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency","volume":"250","author":"Orgov\u00e1n","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib36","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1039\/D5MD00050E","article-title":"Methods for kinetic evaluation of reversible covalent inhibitors from time-dependent IC50 data","volume":"16","author":"Mader","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib37","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1021\/acs.jcim.2c01566","article-title":"Experimental and computational study of aryl-thiosemicarbazones inhibiting Cruzain reveals reversible inhibition and a stepwise mechanism","volume":"63","author":"Martins","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119264_bib38","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1021\/acs.jmedchem.5c00017","article-title":"Size-dependent target engagement of covalent probes","volume":"68","author":"Petri","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib39","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/acs.jmedchem.5c03342","article-title":"Shaping antimalarials: a geometry-first approach to PfCLK3 covalent inhibitors","volume":"69","author":"Brettell","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib40","doi-asserted-by":"crossref","unstructured":"Q. Fan, J. Mei, T. Li, C. Zang, M. Li, J. Tang, Y. Xu, G. Yu, D. Liu, K. Chen, B. Yang, J. Huang, T. Zhou, B. Dang, A high-throughput selection system for fast-acting covalent protein drugs, Science, 392 eadv3081. https:\/\/doi.org\/10.1126\/science.adv3081.","DOI":"10.1126\/science.adv3081"},{"key":"10.1016\/j.ejmech.2026.119264_bib41","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/bloodadvances.2022008447","article-title":"Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance","volume":"7","author":"Naeem","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejmech.2026.119264_bib42","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c03536","article-title":"Tunable aromatic sulfoxides and sulfones as cysteine-targeting warheads: exploring the structure\u2013reactivity relationship","author":"Nystr\u00f6m","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib43","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acs.bioconjchem.3c00322","article-title":"Structure\u2013reactivity studies of 2-Sulfonylpyrimidines allow selective protein arylation","volume":"34","author":"Pichon","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib44","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.3390\/molecules27227728","article-title":"Covalent warheads targeting cysteine residue: the promising approach in drug development","volume":"27","author":"Huang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119264_bib45","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1021\/acs.jpcb.3c05749","article-title":"Understanding cysteine reactivity in protein environments with electric fields","volume":"127","author":"Vaissier Welborn","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.119264_bib46","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1021\/acs.jmedchem.8b01153","article-title":"Emerging and Re-Emerging warheads for targeted covalent inhibitors: applications in medicinal chemistry and chemical biology","volume":"62","author":"Gehringer","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/ars.2019.7963","article-title":"Redox regulation via Glutaredoxin-1 and protein S-Glutathionylation","volume":"32","author":"Matsui","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejmech.2026.119264_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114255","article-title":"Recent applications of vinyl sulfone motif in drug design and discovery","volume":"234","author":"Ahmadi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1021\/acs.jmedchem.1c01719","article-title":"Discovery of cysteine-targeting covalent protein kinase inhibitors","volume":"65","author":"Lu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib50","doi-asserted-by":"crossref","first-page":"20512","DOI":"10.1021\/jacs.5c02801","article-title":"Covalent destabilizing degrader of AR and AR-V7 in androgen-independent prostate cancer cells","volume":"147","author":"Zammit","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib51","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1021\/acschembio.5c00283","article-title":"Small-molecule covalent stabilization and inhibition of the TEAD\u00b7YAP1 transcription factor in cancer cells","volume":"20","author":"Yeh","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118212","article-title":"Design, synthesis and biological evaluation of 8-phenylquinazolin-2-amine derivatives as FLT3 covalent inhibitors targeting cysteine 828 in the ATP pocket","volume":"301","author":"Wei","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117391","article-title":"Design, synthesis and biological evaluation of pyrrolopyrimidine urea derivatives as novel KRASG12C inhibitors for the treatment of cancer","volume":"289","author":"Shang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/2159-8290.CD-24-0840","article-title":"Discovery of BBO-8520, a first-in-class direct and covalent dual inhibitor of GTP-bound (ON) and GDP-bound (OFF) KRASG12C","volume":"15","author":"Maciag","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.119264_bib55","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.4c02939","article-title":"Design, structure optimization, and preclinical characterization of JAB-21822, a covalent inhibitor of KRASG12C","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117047","article-title":"Structure\u2013activity relationship studies of Imidazo[1\u2032,2\u2032:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma","volume":"282","author":"Kim","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib57","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1021\/acs.jmedchem.4c03071","article-title":"Identification of structurally novel KRASG12C inhibitors through covalent DNA-encoded library screening","volume":"68","author":"Huang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108469","article-title":"Optimization of aminoindazole derivatives as highly selective covalent inhibitors for wild-type and mutant FGFR4","volume":"160","author":"Guo","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib59","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/cpt.3390","article-title":"A comparative clinical pharmacology analysis of FDA-approved targeted covalent inhibitors vs. reversible inhibitors in oncology","author":"Ngo","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119264_bib60","series-title":"Lytgobi (Futibatinib) Tablets, for Oral Use","year":"2022"},{"key":"10.1016\/j.ejmech.2026.119264_bib61","series-title":"Krazati (Adagrasib) Tablets, for Oral Use","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119264_bib62","series-title":"Lumakras (Sotorasib) Tablets, for Oral Use","year":"2023"},{"key":"10.1016\/j.ejmech.2026.119264_bib63","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/pharmaceutics15041232","article-title":"Lights and shadows on the cancer multi-target inhibitor rigosertib (ON-01910.Na)","volume":"15","author":"Monfort-Vengut","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119264_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi9284","article-title":"NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation","volume":"10","author":"Jiang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119264_bib64","series-title":"TECFIDERA (Dimethyl Fumarate) delayed-release Capsules, for Oral Use","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119264_bib65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/acsmedchemlett.3c00006","article-title":"Discovery of futibatinib: the first covalent FGFR kinase inhibitor in clinical use","volume":"14","author":"Ito","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib66","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41417-021-00383-9","article-title":"The KRAS-G12C inhibitor: activity and resistance","volume":"29","author":"Liu","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejmech.2026.119264_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107293","article-title":"KRAS G12C in advanced NSCLC: prevalence, co-mutations, and testing","volume":"184","author":"Lim","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejmech.2026.119264_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101974","article-title":"KRAS G12C game of thrones, which direct KRAS inhibitor will claim the iron throne?","volume":"84","author":"Nagasaka","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2026.119264_bib69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-017-0166-z","article-title":"Caspase vinyl sulfone small molecule inhibitors prevent axonal degeneration in human neurons and reverse cognitive impairment in Caspase-6-overexpressing mice","volume":"12","author":"Pakavathkumar","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2026.119264_bib70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/1933719115625846","article-title":"The Nrf2 activator vinylsulfone reduces high glucose-induced neural tube defects by suppressing cellular stress and apoptosis","volume":"23","author":"Dong","year":"2016","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acsmedchemlett.5c00643","article-title":"Design of a targeted covalent probe to interrogate the DNA polymerase activity of Pol\u03b8","volume":"17","author":"Bubenik","year":"2026","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib73","article-title":"Substituted maleimides: self-reportable linkers and tags in bioconjugation, materials science, and nanotechnology","volume":"63","author":"Barker","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib74","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/10717544.2022.2039807","article-title":"Development of applicable thiol-linked antibody\u2013drug conjugates with improved stability and therapeutic index","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejmech.2026.119264_bib75","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2290910","article-title":"Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19","volume":"39","author":"Biernacki","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib76","article-title":"Discovery of covalent and cell-active ALKBH5 inhibitors with potent antileukemia effects in vivo","volume":"64","author":"Wu","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib77","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.7150\/thno.95469","article-title":"From molecules to medicine: thiol selective bioconjugation in synthesis of diagnostic and therapeutic radiopharmaceuticals","volume":"14","author":"Bibi","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.119264_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13007-025-01331-6","article-title":"Rapid detection of tulipalin A with SESI-Orbitrap MS: an exploration across spring flowers","volume":"21","author":"Phan","year":"2025","journal-title":"Plant Methods"},{"key":"10.1016\/j.ejmech.2026.119264_bib79","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1002\/anie.200903108","article-title":"The Renaissance of \u03b1-Methylene-\u03b3-butyrolactones: new synthetic approaches","volume":"48","author":"Kitson","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbrc.2020.08.086","article-title":"Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage","volume":"533","author":"Shi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109689","article-title":"Iso-seco-tanapartholide induces p62 covalent oligomerization to activate KEAP1-NRF2 redox pathway in rheumatoid arthritis","volume":"115","author":"Zhu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2026.119264_bib82","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1021\/acs.jmedchem.5c00833","article-title":"A predictive model for thiol reactivity of N-Heteroaryl \u03b1-Methylene\u2212\u03b3-Lactams\u2500A Medicinally Relevant Covalent reactive group","volume":"68","author":"Meehan","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128713","article-title":"Dimers of isatin derived \u03b1-methylene-\u03b3-butyrolactone as potent anti-cancer agents","volume":"65","author":"Rana","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.03.040","article-title":"Kinetic assessment of Michael addition reactions of alpha, beta-unsaturated carbonyl compounds to amino acid and protein thiols","volume":"169","author":"Sauerland","year":"2021","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.ejmech.2026.119264_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103737","article-title":"Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity","volume":"85","author":"Deng","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib86","doi-asserted-by":"crossref","first-page":"18869","DOI":"10.1021\/acs.jmedchem.5c00462","article-title":"Barbituric acid derivatives as covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase","volume":"68","author":"Froes","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady4492","article-title":"Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy","volume":"11","author":"Nelson","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119264_bib88","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/s41467-025-57005-3","article-title":"Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells","volume":"16","author":"Uguen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202500464","article-title":"Structure-Based development of a covalent inhibitor targeting Streptococcus Pyogenes over Staphylococcus Aureus sortase A","volume":"31","author":"Zhou","year":"2025","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.119264_bib90","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/bjd.19899","article-title":"Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement","volume":"185","author":"Morrison","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2026.119264_bib91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s42004-025-01557-4","article-title":"Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4","volume":"8","author":"Maspero","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117172","article-title":"Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2\/ARE pathway in Parkinson's disease","volume":"494","author":"Chakkittukandiyil","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119264_bib93","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1021\/acs.jmedchem.3c00737","article-title":"Expanding the chemistry of dihaloacetamides as tunable electrophiles for reversible covalent targeting of cysteines","volume":"66","author":"Yamane","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib94","doi-asserted-by":"crossref","first-page":"14832","DOI":"10.1021\/jacs.6b08656","article-title":"Using protein-confined proximity to determine chemical reactivity","volume":"138","author":"Kobayashi","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib95","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/acssensors.5c00640","article-title":"Ratiometric covalent fluorescent probes for dynamic super-resolution imaging of mitochondrial HClO","volume":"10","author":"Lin","year":"2025","journal-title":"ACS Sens."},{"key":"10.1016\/j.ejmech.2026.119264_bib96","doi-asserted-by":"crossref","unstructured":"K.-Y. Ng, T.-Y. Koo, I.B. Huang, T.K.-W. Lee, T.-L. Fong, Y. Gao, T.-L. Wong, Y. Gao, J.-P. Yun, X.-Y. Guan, M. Liu, C.Y.-S. Chung, S. Ma, AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models, Sci. Transl. Med., 17 eadn9472. https:\/\/doi.org\/10.1126\/scitranslmed.adn9472.","DOI":"10.1126\/scitranslmed.adn9472"},{"key":"10.1016\/j.ejmech.2026.119264_bib97","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/acschembio.4c00799","article-title":"Discovery of DCAF16 binders for targeted protein degradation","volume":"20","author":"Campos","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202525126","article-title":"Discovery of a first-in-class covalent allosteric SHP1 inhibitor with immunotherapeutic activity","volume":"65","author":"Qu","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib99","doi-asserted-by":"crossref","first-page":"20697","DOI":"10.1021\/jacs.1c08060","article-title":"Discovery of Di- and trihaloacetamides as covalent SARS-CoV-2 main protease inhibitors with high target specificity","volume":"143","author":"Ma","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib100","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1039\/D1SC06596C","article-title":"Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide","volume":"13","author":"Yamane","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-72993-6","article-title":"\u03b1-Halothioamide warheads with enhanced cysteine reactivity and specificity for covalent protein labelling","author":"Petri","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib102","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1021\/acschembio.4c00025","article-title":"Discovery of a tunable heterocyclic electrophile 4-Chloro-pyrazolopyridine that defines a unique subset of ligandable cysteines","volume":"19","author":"Kim","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib103","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/acsmedchemlett.2c00134","article-title":"Discovery and characterization of a novel series of chloropyrimidines as covalent inhibitors of the kinase MSK1","volume":"13","author":"Hall","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib104","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1021\/acs.jmedchem.3c02483","article-title":"Development of highly potent and selective covalent FGFR4 inhibitors based on SNAr electrophiles","volume":"67","author":"Schwarz","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib105","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/acs.bioconjchem.4c00296","article-title":"Site-Selective antibody conjugation with dibromopyrazines","volume":"35","author":"Szepesi Kov\u00e1cs","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib106","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1021\/acschembio.5c00475","article-title":"Structural elucidation and covalent modulation of the autorepressed Orphan nuclear receptor NR2F6","volume":"20","author":"Oerlemans","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib107","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c02644","article-title":"Design of benzyl-triazolopyrimidine-based NADPH oxidase inhibitors leads to the discovery of a potent dual covalent NOX2\/MAOB inhibitor","volume":"68","author":"Noce","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70053","article-title":"Design, synthesis, and molecular evaluation of SNAr-Reactive N-(6-Fluoro-3-Nitropyridin-2-yl)Isoquinolin-3-Amines as covalent USP7 inhibitors reveals an unconventional binding mode","volume":"358","author":"Ernst","year":"2025","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2026.119264_bib109","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acsptsci.5c00110","article-title":"Mechanistic insights of a p53-Targeting small molecule","volume":"8","author":"Ferreira","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib110","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1021\/jacs.0c10513","article-title":"Exploring the versatility of the covalent Thiol\u2013alkyne reaction with substituted Propargyl warheads: a deciding role for the cysteine protease","volume":"143","author":"Mons","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib111","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acs.jmedchem.5c03015","article-title":"Discovery of coronavirus main protease inhibitors with enhanced brain exposure and potent oral efficacy in SARS-CoV-2 and MERS infection models","volume":"69","author":"Lizzadro","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib112","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/acs.jmedchem.2c01360","article-title":"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins","volume":"66","author":"Behring","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib113","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/acs.jmedchem.9b01617","article-title":"Acetylene group, friend or foe in medicinal chemistry","volume":"63","author":"Talele","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib114","article-title":"Lab-in-Cell: a covalent photosensitizer reverses hypoxia and evokes ferroptosis and pyroptosis for enhanced anti-tumor immunity","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2026.119264_bib115","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1038\/s41467-025-64669-4","article-title":"Rational design of potent small-molecule SMARCA2\/A4 degraders acting via the recruitment of FBXO22","volume":"16","author":"Villemure","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib116","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/acs.jmedchem.5c01451","article-title":"Discovery of a highly potent and selective small-molecule inhibitor of in vivo Anaerobic Choline metabolism by Human Gut bacteria","volume":"69","author":"Pettersson","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib117","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/acs.jmedchem.5c01973","article-title":"Structure-Guided design of potent and selective covalent inhibitors targeting the SARS-CoV-2 papain-like protease","volume":"69","author":"Sharafi","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib118","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/dmd.118.084459","article-title":"Bioavailability, biotransformation, and excretion of the covalent Bruton Tyrosine Kinase inhibitor acalabrutinib in rats, dogs, and humans","volume":"47","author":"Terry","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2026.119264_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060563","article-title":"Chemical conjugation strategies for the development of protein-based subunit nanovaccines","volume":"9","author":"Lu","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ejmech.2026.119264_bib120","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.orglett.9b02117","article-title":"Isothiocyanates as H2S donors triggered by cysteine: reaction mechanism and structure and activity relationship","volume":"21","author":"Lin","year":"2019","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib121","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1039\/D0RA02934C","article-title":"Cysteine specific bioconjugation with benzyl isothiocyanates","volume":"10","author":"Petri","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119264_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105741","article-title":"A new isothiocyanate-based Golgi-targeting fluorescent probe for Cys and its bioimaging applications during the Golgi stress response","volume":"122","author":"Zhu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib123","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1021\/acs.jmedchem.0c01137","article-title":"Design and characterization of an intracellular covalent ligand for CC chemokine receptor 2","volume":"64","author":"Ortiz Zacar\u00edas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib124","doi-asserted-by":"crossref","first-page":"15873","DOI":"10.1021\/acs.jmedchem.4c01558","article-title":"Discovery of a covalent inhibitor of Pro-Caspase-1 zymogen blocking NLRP3 inflammasome activation and pyroptosis","volume":"67","author":"Cao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s42114-020-00137-5","article-title":"Two-stage reactive shape memory thiol\u2013epoxy\u2013acrylate system and application in 3D structure design","volume":"3","author":"Wang","year":"2020","journal-title":"Adv. Compos. Hybrid Mater."},{"key":"10.1016\/j.ejmech.2026.119264_bib126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas Matthew","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119264_bib127","doi-asserted-by":"crossref","first-page":"18335","DOI":"10.1021\/acs.jmedchem.5c00980","article-title":"Development of low-nanomolar covalent epoxide inhibitors of tubulin detyrosinating enzymes VASH1&2","volume":"68","author":"Feral","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105862","article-title":"Epoxides: developability as active pharmaceutical ingredients and biochemical probes","volume":"125","author":"Kaur","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/acsmedchemlett.4c00460","article-title":"Discovery of a potent triazole-based reversible targeted covalent inhibitor of cruzipain","volume":"16","author":"Cerutti","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib130","first-page":"2","article-title":"Review article: the clinical pharmacology of proton pump inhibitors, aliment","volume":"23","author":"Sachs","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119264_bib131","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bmc.2019.04.002","article-title":"Characterising covalent warhead reactivity","volume":"27","author":"Martin","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115028","article-title":"Discovery of cysteine-targeting covalent histone methyltransferase inhibitors","volume":"246","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib133","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1021\/jacs.7b01791","article-title":"Diverse redoxome reactivity profiles of carbon nucleophiles","volume":"139","author":"Gupta","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib134","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.cell.2024.03.027","article-title":"DrugMap: a quantitative pan-cancer analysis of cysteine ligandability","volume":"187","author":"Takahashi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119264_bib135","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1021\/acs.jmedchem.2c01563","article-title":"Selective covalent targeting of pyruvate kinase M2 using arsenous warheads","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib136","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ajoc.202100036","article-title":"New cysteine covalent modification strategies enable advancement of proteome-wide selectivity of kinase modulators","volume":"10","author":"Guan","year":"2021","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib137","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1039\/D2MD00216G","article-title":"Advanced approaches of developing targeted covalent drugs","volume":"13","author":"Gai","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib138","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1038\/s41467-024-52573-2","article-title":"Reversible covalent c-Jun N-terminal kinase inhibitors targeting a specific cysteine by precision-guided Michael-acceptor warheads","volume":"15","author":"B\u00e1lint","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib139","article-title":"Fast cysteine bioconjugation chemistry","volume":"28","author":"Chen","year":"2022","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.119264_bib140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acschembio.2c00633","article-title":"Profiling Sulfur(VI) fluorides as reactive functionalities for chemical biology tools and expansion of the ligandable proteome","volume":"18","author":"Gilbert","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib141","doi-asserted-by":"crossref","DOI":"10.1116\/6.0000910","article-title":"Detection of gold cysteine thiolate complexes on gold nanoparticles with time-of-flight secondary ion mass spectrometry","volume":"16","author":"Nie","year":"2021","journal-title":"Biointerphases"},{"key":"10.1016\/j.ejmech.2026.119264_bib142","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1039\/D2CC01259F","article-title":"Competitive profiling of ligandable cysteines in Staphylococcus aureus with an organogold compound","volume":"58","author":"Schmidt","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib143","doi-asserted-by":"crossref","first-page":"14582","DOI":"10.1021\/acs.inorgchem.1c01517","article-title":"Tuning cyclometalated Gold(III) for cysteine arylation and ligand-directed bioconjugation","volume":"60","author":"Gukathasan","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202516331","article-title":"Cyclometalated Gold(III)-Mediated cysteine arylation: a bioorthogonal platform for covalent targeting of intrinsically disordered proteins","volume":"64","author":"Munugoda","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib145","article-title":"Gold-templated covalent targeting of the CysSec-dyad of thioredoxin reductase 1 in cancer cells, cell rep","volume":"5","author":"Skos","year":"2024","journal-title":"Phys. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib146","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.200545","article-title":"Characterization of platinum(II) complexes exhibiting inhibitory activity against the 20S proteasome","volume":"7","author":"Kiwada","year":"2020","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib147","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s42004-024-01279-z","article-title":"Development of ketalized unsaturated saccharides as multifunctional cysteine-targeting covalent warheads","volume":"7","author":"Dong","year":"2024","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112500","article-title":"Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes","volume":"203","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115345","article-title":"Design, synthesis and biological evaluation of novel thiosemicarbazones as cruzipain inhibitors","volume":"254","author":"Jasinski","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib150","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1021\/acs.jmedchem.2c00636","article-title":"Small-molecule thioesters as SARS-CoV-2 main protease inhibitors: enzyme inhibition, structure\u2013activity relationships, antiviral activity, and X-ray structure determination","volume":"65","author":"Pillaiyar","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib151","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1021\/acs.joc.3c00200","article-title":"Alkyl thiocyanurates as thioester mimetics. Transthioesterification and ligation reactions with high potential in dynamic covalent chemistry","volume":"88","author":"Wo\u0142cza\u0144ski","year":"2023","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib152","doi-asserted-by":"crossref","first-page":"10665","DOI":"10.1021\/acs.jmedchem.8b01308","article-title":"Identification of cyanamide-based janus kinase 3 (JAK3) covalent inhibitors","volume":"61","author":"Casimiro-Garcia","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib153","doi-asserted-by":"crossref","first-page":"18355","DOI":"10.1074\/jbc.RA120.014883","article-title":"Nitro-fatty acids as activators of hSIRT6 deacetylase activity","volume":"295","author":"Carre\u00f1o","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2022.100025","article-title":"Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease","volume":"2","author":"Yang","year":"2022","journal-title":"Curr. Res. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib155","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1039\/C9SC01345H","article-title":"Vinylphosphonites for Staudinger-induced chemoselective peptide cyclization and functionalization","volume":"10","author":"Kasper","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib156","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1002\/anie.201814715","article-title":"Cysteine-selective phosphonamidate electrophiles for modular protein bioconjugations","volume":"58","author":"Kasper","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib157","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1039\/D1SC01730F","article-title":"The mechanism behind enhanced reactivity of unsaturated phosphorus(v) electrophiles towards thiols","volume":"12","author":"Park","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib158","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.5c22349","article-title":"Modular vinyl phosphonamidates for cysteine-directed protein targeting","author":"Stieger","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib159","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/acschembio.9b00982","article-title":"Discovery of novel antibiotics as covalent inhibitors of fatty acid synthesis","volume":"15","author":"Wang","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115286","article-title":"Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells","volume":"254","author":"Galbiati","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib161","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1021\/jacs.3c00598","article-title":"Covalent inhibition by a natural product-inspired latent electrophile","volume":"145","author":"Byun","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib162","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1039\/D4SC08667H","article-title":"Total syntheses of cyclohelminthol I\u2013IV reveal a new cysteine-selective covalent reactive group","volume":"16","author":"Paulsen","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib163","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cbpa.2016.08.011","article-title":"Targeting biomolecules with reversible covalent chemistry","volume":"34","author":"Bandyopadhyay","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib164","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1039\/D2MD00204C","article-title":"Nitriles: an attractive approach to the development of covalent inhibitors","volume":"14","author":"Bonatto","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/acsmedchemlett.9b00168","article-title":"Thioimidate bond formation between cardiac troponin C and nitrile-containing compounds","volume":"10","author":"Klein","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib166","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/acs.jcim.2c00458","article-title":"Discovery and computational studies of potent covalent kinase inhibitors with \u03b1-Substituent electrophiles targeting cysteine","volume":"63","author":"Ai","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119264_bib167","doi-asserted-by":"crossref","first-page":"9517","DOI":"10.1021\/acs.jcim.4c00890","article-title":"Exploring extended warheads toward developing cysteine-targeted covalent kinase inhibitors","volume":"64","author":"Zhao","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119264_bib168","doi-asserted-by":"crossref","first-page":"35481","DOI":"10.1021\/jacs.5c09857","article-title":"Discovery of BRD9 molecular glue degraders that spare cardiomyocytes","volume":"147","author":"Byun","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib169","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/jacs.3c08762","article-title":"The nitrile Bis-Thiol bioconjugation reaction","volume":"146","author":"Patel","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib170","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1021\/acs.jmedchem.4c02464","article-title":"Structural optimization of covalent inhibitors for deubiquitinase ChlaDUB1 of Chlamydia trachomatis as antibiotic agents","volume":"68","author":"Zimmermann","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib171","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1021\/acs.jmedchem.6c00889","article-title":"New reversible covalent warheads: cyanobenzothiazoles recruiting DCAF16 for targeted protein degradation","volume":"69","author":"Zhang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib172","doi-asserted-by":"crossref","first-page":"11946","DOI":"10.1039\/D4SC01940G","article-title":"Isocyanides inhibit bacterial pathogens by covalent targeting of essential metabolic enzymes","volume":"15","author":"Gei\u00dfler","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109022","article-title":"Rational DESIGN and structure-activity relationship study of novel JOSD2 inhibitor against colorectal cancer","volume":"166","author":"Liu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020217","article-title":"The design, synthesis and mechanism of action of Paxlovid, a protease inhibitor drug combination for the treatment of COVID-19","volume":"16","author":"Bege","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119264_bib175","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119264_bib176","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1021\/acs.jmedchem.2c01627","article-title":"Alkyne derivatives of SARS-CoV-2 main protease inhibitors including nirmatrelvir inhibit by reacting covalently with the Nucleophilic Cysteine","volume":"66","author":"Brewitz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117603","article-title":"Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies","volume":"291","author":"Laczi","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib178","doi-asserted-by":"crossref","first-page":"13436","DOI":"10.1021\/acs.jmedchem.5c00088","article-title":"Discovery and preclinical profile of ALG-097558, a pan-coronavirus 3CLpro inhibitor","volume":"68","author":"Bardiot","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib179","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/acs.jmedchem.3c02076","article-title":"Reinvent aliphatic arsenicals as reversible covalent warheads toward targeted kinase inhibition and non-acute promyelocytic leukemia cancer treatment","volume":"67","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib180","doi-asserted-by":"crossref","first-page":"12322","DOI":"10.1021\/acs.jmedchem.1c01002","article-title":"Fluorovinylsulfones and -Sulfonates as potent covalent reversible inhibitors of the trypanosomal cysteine protease rhodesain: Structure\u2013activity relationship, inhibition mechanism, metabolism, and in vivo studies","volume":"64","author":"Jung","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib181","doi-asserted-by":"crossref","first-page":"37065","DOI":"10.1021\/jacs.5c07422","article-title":"\u03b2-Fluorovinylsulfonamide as a highly Reactivity- and structure-tunable electrophile for covalent targeting of proteins","volume":"147","author":"Watanabe","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib182","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1039\/D5SC02647D","article-title":"Advances in sulfonyl exchange chemical biology: expanding druggable target space","volume":"16","author":"Jones","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib183","doi-asserted-by":"crossref","first-page":"25933","DOI":"10.1002\/anie.202110027","article-title":"Inhibition mechanism of SARS-CoV-2 main protease with ketone-based inhibitors unveiled by multiscale simulations: insights for improved designs","volume":"60","author":"Ramos-Guzm\u00e1n","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111620","article-title":"Thiazole-fused thiazoliniums with ketone warheads as covalent inhibitors targeting Cys44 of SARS-CoV-2 3CLpro","volume":"418","author":"Cao","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2026.119264_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202500380","article-title":"The reactivity of \u03b1-Fluorinated Mono- and diketones uncovers their potential as Electrophilic warheads for reversible covalent drugs","volume":"28","author":"Zafrani","year":"2025","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib186","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1039\/D3SC06551K","article-title":"Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism","volume":"15","author":"John","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib187","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acs.bioconjchem.3c00322","article-title":"Structure\u2013reactivity studies of 2-Sulfonylpyrimidines allow selective protein arylation","volume":"34","author":"Pichon","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib188","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1039\/D1MD00068C","article-title":"Recent advances in the development of covalent inhibitors","volume":"12","author":"Kim","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib189","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121484","article-title":"Next-generation heterocyclic electrophiles as small-molecule covalent MurA inhibitors","volume":"15","author":"\u00c1br\u00e1nyi-Balogh","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119264_bib190","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1021\/jacs.9b13391","article-title":"Alkynyl benzoxazines and dihydroquinazolines as cysteine targeting covalent warheads and their application in identification of selective irreversible kinase inhibitors","volume":"142","author":"McAulay","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib191","doi-asserted-by":"crossref","first-page":"11602","DOI":"10.1021\/acs.jmedchem.0c00749","article-title":"Systematic study of the glutathione reactivity of N-Phenylacrylamides: 2. Effects of acrylamide substitution","volume":"63","author":"Birkholz","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib192","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1021\/jacs.0c10644","article-title":"Tunable methacrylamides for covalent ligand directed release chemistry","volume":"143","author":"Reddi","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib193","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.bmc.2018.03.006","article-title":"Structure-activity relationships in a new class of non-substrate-like covalent inhibitors of the bacterial glycosyltransferase LgtC","volume":"26","author":"Xu","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib194","doi-asserted-by":"crossref","first-page":"24140","DOI":"10.1021\/jacs.5c08170","article-title":"Overcoming the hydrolytic susceptibility of thiol-reactive reversible warheads through the development of substituted phenyl cyanoacrylamides","volume":"147","author":"Nambiar","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib195","author":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119264_bib196","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-021-23313-7","article-title":"Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives","volume":"12","author":"Amporndanai","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib197","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1038\/s41598-023-35907-w","article-title":"Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: plpro and Mpro proteases, and nsp14 guanine N7-methyltransferase","volume":"13","author":"Zmudzinski","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119264_bib198","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119264_bib199","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1021\/acsmedchemlett.0c00323","article-title":"Hydrogen peroxide inducible JAK3 covalent inhibitor: prodrug for the treatment of RA with enhanced safety profile","volume":"11","author":"Bao","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib200","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1021\/acs.jmedchem.4c02334","article-title":"Design of ROS-Triggered sesquiterpene lactone SC prodrugs as TrxR1 covalent inhibitors for the treatment of non-small cell lung cancer","volume":"68","author":"Ren","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.tchem.2024.100070","article-title":"Strain-release transformations of bicyclo[1.1.0]butanes and [1.1.1]propellanes","volume":"9","author":"Hu","year":"2024","journal-title":"Tetrahedron Chem"},{"key":"10.1016\/j.ejmech.2026.119264_bib202","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.1021\/jacs.0c07490","article-title":"Bicyclobutane carboxylic amide as a cysteine-directed strained electrophile for selective targeting of proteins","volume":"142","author":"Tokunaga","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202420028","article-title":"Synthesis and functionalization of Sulfoximine-Bicyclo[1.1.0]butanes: functionalizable, tuneable and cysteine-selective chiral warheads","volume":"64","author":"Zhong","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib204","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1039\/D3SC00224A","article-title":"Chemoselective bicyclobutane-based mass spectrometric detection of biological thiols uncovers human and bacterial metabolites","volume":"14","author":"Kaur","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119264_bib205","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41589-020-0626-6","article-title":"Covalent inhibition of NSD1 histone methyltransferase","volume":"16","author":"Huang","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib206","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41401-020-00534-y","article-title":"Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo","volume":"42","author":"Ma","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.119264_bib207","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1021\/acs.jmedchem.5c00424","article-title":"Fragment-based drug design: from then until now, and toward the future","volume":"68","author":"Xu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1379518","article-title":"Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece","volume":"12","author":"Chan","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib209","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1039\/D3RA00426K","article-title":"A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication","volume":"13","author":"Han","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119264_bib210","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.drudis.2020.03.016","article-title":"Covalent fragment libraries in drug discovery","volume":"25","author":"Keeley","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119264_bib211","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.6c03985","article-title":"A global ligandability map of tryptoline Butynamide stereoprobes identifies covalent inhibitors of the actin maturation protease","author":"Xiong","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100198","article-title":"Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors","volume":"29","author":"Ficarro","year":"2024","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.ejmech.2026.119264_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.834453","article-title":"Fragment-Based drug discovery by NMR. Where are the successes and where can it be improved?","volume":"9","author":"Mureddu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.119264_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.861491","article-title":"Experiences from developing software for large X-Ray crystallography-driven protein-ligand studies","volume":"9","author":"Pearce","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.119264_bib215","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1016\/j.bmc.2019.05.050","article-title":"Opportunities and challenges for the development of covalent chemical immunomodulators","volume":"27","author":"Backus","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib216","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41589-024-01738-7","article-title":"An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes","volume":"21","author":"Zhang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib217","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.chembiol.2025.08.004","article-title":"A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer","volume":"32","author":"Koo","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib218","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.chembiol.2025.02.001","article-title":"Antibiotic target discovery by integrated phenotypic and activity-based profiling of electrophilic fragments","volume":"32","author":"Jin","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119264_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202418314","article-title":"Expedited SARS-CoV-2 main protease inhibitor discovery through modular \u2018Direct-to-Biology\u2019 screening","volume":"64","author":"Wilders","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119264_bib220","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1021\/jacs.5c18150","article-title":"Group competition strategy for covalent ligand discovery","volume":"148","author":"Guo","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119264_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115632","article-title":"An electrophilic fragment screening for the development of small molecules targeting caspase-2","volume":"259","author":"Cuellar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130176","article-title":"Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors","volume":"122","author":"He","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119264_bib223","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1021\/acs.jmedchem.3c01661","article-title":"Covalent fragment screening and optimization identifies the chloroacetohydrazide scaffold as inhibitors for ubiquitin C-terminal hydrolase L1","volume":"67","author":"Imhoff","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119264_bib224","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chembiol.2023.02.008","article-title":"Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-\u03baB","volume":"30","author":"King","year":"2023","journal-title":"Cell Chem. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:03:02Z","timestamp":1793977382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":224,"alternative-id":["S0223523426007099"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119264","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cysteine-targeting covalent inhibition: Recent trends and emerging strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119264"}}